发明名称 Multi-stage oral drug controlled-release system
摘要 A multi-stage oral drug controlled-release system is disclosed, as well as a preparation for maintaining the drug blood concentration at a desired level for a prolonged time. The system operates by releasing the drug at a constant rate through stepwise control of drug release following administration of the preparation. More specifically, the multi-stage oral drug controlled-release system involves the stepwise release of drug-containing granules from an inner matrix, which is surrounded by a coating or release-modifying layer. The granules contain an active drug and a carrier material in size of 0.1~1 mm. The carrier material is hydrophobic when the drug has a water-solubility of 1 mg/ml or more, and is hydrophilic when the drug has a water-solubility of less than 1 mg/ml. The inner matrix, in which the drug-containing granules are embedded, is formed from swelling and erodible polymer(s) and swelling-regulating material(s). The release-modifying layer is composed of a hydrophobic release-modifying polymer, a hydrophilic release-modifying polymer, pH-dependent release-modifying polymer or mixtures thereof.
申请公布号 US2003180362(A1) 申请公布日期 2003.09.25
申请号 US20030357821 申请日期 2003.02.03
申请人 PACIFIC CORPORATION 发明人 PARK JIN WOO;BAE JOON HO;KIM JUNG JU
分类号 A61K47/30;A61K9/16;A61K9/20;A61K9/26;A61K9/28;A61K9/32;A61K31/137;A61K31/216;A61K31/401;A61K31/407;A61K31/522;A61K31/554;A61K38/55;A61K47/10;A61K47/12;A61K47/14;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/44;A61P3/14;A61P9/12;A61P13/10;A61P29/00;A61P43/00;(IPC1-7):A61K9/26;A61K9/14 主分类号 A61K47/30
代理机构 代理人
主权项
地址